Analysts Set Agilon Health, Inc. (NYSE:AGL) PT at $50.20

Agilon Health, Inc. (NYSE:AGL) has been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $40.2250.

A number of equities research analysts recently weighed in on AGL shares. Benchmark boosted their price objective on shares of Agilon Health to $13.00 and gave the company a “buy” rating in a research report on Thursday, April 2nd. Barclays lowered their price objective on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a research report on Friday, February 27th. Citigroup decreased their target price on shares of Agilon Health from $21.25 to $18.75 and set a “neutral” rating for the company in a research report on Tuesday, March 3rd. Wells Fargo & Company upped their target price on shares of Agilon Health from $25.00 to $37.50 and gave the stock an “overweight” rating in a research report on Friday, February 27th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Wealthcare Advisory Partners LLC acquired a new stake in Agilon Health during the third quarter valued at approximately $26,000. LPL Financial LLC lifted its stake in Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares during the last quarter. Krilogy Financial LLC acquired a new stake in Agilon Health during the fourth quarter valued at approximately $34,000. CIBC Bancorp USA Inc. acquired a new stake in Agilon Health during the third quarter valued at approximately $34,000. Finally, Merit Financial Group LLC acquired a new stake in Agilon Health during the fourth quarter valued at approximately $35,000.

Agilon Health Price Performance

Shares of NYSE:AGL opened at $30.73 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. Agilon Health has a fifty-two week low of $7.48 and a fifty-two week high of $120.25. The firm has a 50-day simple moving average of $13.88 and a 200 day simple moving average of $17.97. The company has a market cap of $509.86 million, a PE ratio of -1.29 and a beta of 0.33.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. The business had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, sell-side analysts anticipate that Agilon Health will post -0.59 EPS for the current year.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.